DCPH — Deciphera Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.21bn
- $1.94bn
- $163.36m
U.S. RESEARCH ROUNDUP-Charter Communications, Guild Holdings, Waste Management
U.S. RESEARCH ROUNDUP- Booking Holdings, Carvana, Kroger
Brief: Deciphera Pharmaceuticals Presents Initial Phase 1 Single Agent Dose Escalation Data For First-In-Class ULK Inhibitor Of Autophagy DCC-3116
U.S. STOCKS ON THE MOVE-Envista, Bed Bath & Beyond, United Parcel Service
U.S. STOCKS ON THE MOVE-Astra Space, Ammo, Chimerix
U.S. STOCKS ON THE MOVE-Pinduoduo, NetApp, Clean Energy Fuels
Cowen sees strong growth prospects for Deciphera Pharma's cancer drug
U.S. RESEARCH ROUNDUP-Isoplexis, Seer, Wesco International
Brief: Deciphera Pharmaceuticals, Inc. Announces Publication Of Intrigue Phase 3 Clinical Study Results In Journal Of Clinical Oncology
U.S. RESEARCH ROUNDUP- Avalara, Global Blood Therapeutics, Tyson Foods
U.S. RESEARCH ROUNDUP-Enovix, IRhythm Technologies, Paramount Global
Brief: Deciphera Pharmaceuticals Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing
Brief: Deciphera Pharma Reports Q2 2022 Financial Results
Deciphera Pharmaceuticals Inc expected to post a loss of 66 cents a share - Earnings Preview
Deciphera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Deciphera Pharmaceuticals Announces First Quarter 2022 Results
Brief: Deciphera Pharmaceuticals Says Qtrly Loss Per Share $0.80
Deciphera Pharmaceuticals Inc expected to post a loss of 91 cents a share - Earnings Preview
Deciphera Pharma down after $150 mln stock offering